At separate institutions, pattern reversal visual evoked potentials (VEPs) were recorded in children and older patients with phenylketonuria and compared with MRI of the brain. In nine patients aged less than 14 years, who were still on a diet low in phenylalanine, VEPs were clearly abnormal in only one and the abnormalities seen on MRI were mild. In 27 patients aged 14-31 years VEPs were abnormal in more than 80%, with significant reduction of amplitude and prolongation of latency despite the general absence of visual symptoms and abnormalities on routine neuro-ophthalmological examination. Among the older patients there was no significant correlation between VEP measures and plasma phenylalanine or tyrosine concentrations; neither was the incidence of VEP abnormalities dependent on whether or not the patients were still on a low phenylalanine diet. Some VEP amplitude measures were inversely correlated with the MRI lesion score, perhaps reflecting the severity of white matter abnormalities in the parieto-occipital region. In the older patients the amplitude of VEPs to stimulation of the central 80 of the visual field was significantly correlated with IQ. The study confirms the high incidence of subclinical visual pathway involvement in older children and adults with phenylketonuria, and suggests the possibility of a link between the abnormal appearance of subcortical white matter on MRI and a physiological index of function of the CNS. As there was no evidence of general intellectual decline, it is suggested that the correlation between central field VEP amplitude and IQ may reflect abnormal development during infancy. Abnormalities on MRI, on the other hand, seem to be more closely related to current dietary state and phenylalanine concentration. (_ Neurol Neurosurg Psychiatry 1995;59:260-265) 
Abstract
At separate institutions, pattern reversal visual evoked potentials (VEPs) were recorded in children and older patients with phenylketonuria and compared with MRI of the brain. In nine patients aged less than 14 years, who were still on a diet low in phenylalanine, VEPs were clearly abnormal in only one and the abnormalities seen on MRI were mild. In 27 patients aged 14-31 years VEPs were abnormal in more than 80%, with significant reduction of amplitude and prolongation of latency despite the general absence of visual symptoms and abnormalities on routine neuro-ophthalmological examination. Among the older patients there was no significant correlation between VEP measures and plasma phenylalanine or tyrosine concentrations; neither was the incidence of VEP abnormalities dependent on whether or not the patients were still on a low phenylalanine diet. Some VEP amplitude measures were inversely correlated with the MRI lesion score, perhaps reflecting the severity of white matter abnormalities in the parieto-occipital region. In the older patients the amplitude of VEPs to stimulation of the central 80 of the visual field was significantly correlated with IQ. The study confirms the high incidence of subclinical visual pathway involvement in older children and adults with phenylketonuria, and suggests the possibility of a link between the abnormal appearance of subcortical white matter on MRI and a physiological index of function of the CNS. As there was no evidence of general intellectual decline, it is suggested that the correlation between central field VEP amplitude and IQ may reflect abnormal development during infancy. Abnormalities Visual evoked potentials (VEPs) are often abnormal in both untreated'314 and treated patients with phenylketonuria.'5-'9 The locus of the abnormality has not been determined, but the common finding of prolonged VEP latencies suggests a central myelin defect causing slowing of conduction in fibres of the optic nerves or sensory radiations.
In a previous paper, the severity of MRI abnormalities in the brains of 34 patients with phenylketonuria was reported to be independently correlated with the degree of hyperphenylalaninaemia and the time elapsed since the patients had ceased taking a low phenylalanine diet.8 Abnormal neurological signs such as brisk limb reflexes, tremors, or epilepsy were detected in 40% of early diagnosed cases. Abnormalities on MRI were often most conspicuous in the parieto-occipital region. In the present investigation we studied an overlapping group of 36 patients, including nine children aged less than 14 For the older patients the checkerboard was back projected on to a centrally fixated, who commenced treatment at an early age there was a difference approaching significance (t = 2-09, P < 0.1) between the VEP latencies of seven who were still on a low phenylalanine diet at the time of the study and 10 who had changed to a normal diet; however, the VEP latencies were on average slightly longer in the controlled diet group, suggesting that this could have been a chance finding.
.00 Our study confirms previous reports that ainder, the central field VEP abnormalities are frequent even among des were still significantly early diagnosed cases. The electrophysiologi-2 (left eye r = 0-582 P < cal abnormalities were correlated, albeit = 0 543 P < 0-02, fig 3) . weakly, with the MRI lesion score, suggesting ents of the overall group in that it may be a myelin defect in the subcorti-2 score was available, this cal white matter which is responsible for the lated with the patient's age decreased VEP amplitude and prolonged VEP recording (r = J-0454 latency. However, as there was no direct evithe 25 older patients IQ dence of a link between subcortical white ntly correlated with age matter involvement and VEP abnormalities P < 0 2). study this possibility cannot be excluded. The incidence of VEP abnormalities was weakly associated with that of plasma phenylalanine concentrations above 1200 umol/l, but no correlation could be established between phenylalanine concentrations and parametric VEP measures. It must be stressed that the younger patients of the present study were recorded in a different centre with slightly different methods, and their test may have been less sensitive on account of the greater difficulty young subjects have in maintaining concentration on the stimulus screen.
A second notable finding was a significant correlation between central field VEP amplitudes and the patients' IQ, after taking measures to try to ensure that this was not a trivial consequence of poor attention to the stimulus. No correlation between VEP amplitude and IQ has been shown for normal subjects, and IQ in patients with phenylketonuria is rather stable throughout the later years of childhood and early adulthood (the correlation of IQ with age was non-significant for the patients aged 14 and older). Therefore it is argued that the reduction in central field VEP amplitude may reflect events occurring during early development which also determine intellectual state in later life. The abnormal VEPs could signal a dysfunction of the subcortical white matter which is also reflected by the changes seen in MRI, but the latter were not found to be significantly correlated with IQ8 and were more strongly associated with current phenylalanine concentrations.
It is concluded that VEPs disclose a high incidence of abnormalities in adult patients with phenylketonuria, correlating to a small degree with the severity of brain tissue changes seen in MRI and plasma phenylalanine concentrations but more strongly with intellectual performance. By contrast with MRI changes, which are to some extent associated with current phenylalanine concentrations, the VEP abnormalities seem to be more closely linked with earlier events which may also be involved in the determination of IQ. Although VEPs may prove to be relatively insensitive to late onset neurological deterioration, the high incidence of abnormalities among early diagnosed patients irrespective of their dietary history re-emphasises the need for further studies on the relation between early diet and long term neurological integrity.
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